Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
Just over half of U.S. teens say they have used chatbots for help with schoolwork, and 12% say they’ve gotten emotional support from these tools. Teens tend to view the future impact of AI on their ...
WASHINGTON— The Supreme Court agreed Monday to decide whether people picked up on immigration violations also can face charges of identity theft if they use Social Security and other identification ...
Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, economics, and public policy. Peter began covering markets at Multex (Reuters) and has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results